Reevaluation Of Systemic Early Neuromuscular Blockade
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- David A. Schoenfeld, PhD
Massachusetts General Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
44 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Ucsf Fresno
Fresno, California, United States
- Ronald Reagan Ucla Medical Center
Los Angeles, California, United States
- Uc Davis Medical Center
Sacramento, California, United States
- Ucsf Medical Center
San Francisco, California, United States
- Stanford University Hospital
Stanford, California, United States
- Medical Center of Aurora
Aurora, Colorado, United States
- University of Colorado Hospital
Aurora, Colorado, United States
- Denver Health Medical Center
Denver, Colorado, United States
- Swedish Medical Center
Englewood, Colorado, United States
- Indiana University Methodist Hospital
Indianapolis, Indiana, United States
- University Medical Center
New Orleans, Louisiana, United States
- Maine Medical Center
Portland, Maine, United States
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- Tufts Medical Center
Boston, Massachusetts, United States
- Baystate Medical Center
Springfield, Massachusetts, United States
- St. Vincent'S Hospital
Worcester, Massachusetts, United States
- University of Michigan Medical Center
Ann Arbor, Michigan, United States
- Henry Ford Medical Center
Detroit, Michigan, United States
- University of Mississippi Medical Center
Jackson, Mississippi, United States
- Mt. Sinai Hospital
New York, New York, United States
- Montefiore Medical Center
The Bronx, New York, United States
- Wesley Long Hospital
Greensboro, North Carolina, United States
- Wake Forest Baptist Medical Center
Winston-Salem, North Carolina, United States
- Summa Akron City Hospital
Akron, Ohio, United States
- University of Cincinnati Medical Center
Cincinnati, Ohio, United States
- Cleveland Clinic Foundation
Cleveland, Ohio, United States
- Ohio State University Wexner Medical Center
Columbus, Ohio, United States
- Oregon Health and Science University
Portland, Oregon, United States
- Penn State Hershey Medical Center
Hershey, Pennsylvania, United States
- Upmc Presbyterian/mercy/shadyside
Pittsburgh, Pennsylvania, United States
- Vanderbilt University Medical Center
Nashville, Tennessee, United States
- Intermountain Medical Center
Murray, Utah, United States
- Mckay-Dee Hospital
Ogden, Utah, United States
- Utah Valley Regional Medical Center
Provo, Utah, United States
- Lds Hospital
Salt Lake City, Utah, United States
- University Hospital
Salt Lake City, Utah, United States
- University Or Virginia Health System
Charlottesville, Virginia, United States
- Vcu Medical Center
Richmond, Virginia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 4 Jan 2016
- Primary completion
- 3 Jul 2018
- Completion
- 4 Apr 2019
- Last update posted
- 13 Aug 2019
- Registered enrollment
- 1,008
- Registry id
- NCT02509078
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.